The global biosurgery market is anticipated to grow at a CAGR of around 7.9% over the forecast period 2019 to 2026 and expected to reach around 19,940.4 Mn by 2026.
Biosurgery is a term used for surgical techniques that uses a wide range of natural and manmade materials, where biomaterials are biologically compatible glues and lubricants and the term also covers the biocompatible materials like hip replacements and artificial pacemakers. Biosurgery also includes biotherapeutic techniques, such as gene and cellular therapies. Surgical sealants and adhesives, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple line reinforcement agents are some of the common biosurgery products. These are used in various surgeries to minimize intra and post-operative complications. These help in preventing excessive blood loss, providing adhesion or wound/tissue sealing, also to repair damaged or weakened tissues or bones of a body. Moreover, biosurgery products control surgery-related difficulties in expensive and complicated surgeries and simultaneously enhance the efficiency of physicians.
The rising geriatric population across the globe coupled with the increasing number of surgeries is primarily accelerating the market growth. Rising prevalence of severe trauma injuries along with the rising need for effective blood loss management in patients is additionally propelling the demand in the global market. In addition, a strong focus on R&D, which leads to the launch of new and advanced products, is further bolstering the market value.
However, the high price of biosurgery products and the rising cost of surgical procedures are likely to limit market growth. Moreover, stringent regulatory networks and the requirement of skilled professionals who can effectively use biosurgery products are expected to be the major challenges through the forecast period. Whereas, untapped emerging economies are anticipated to create potential opportunities over the forecast period.
On the basis of products, surgical sealants are expected to dominate the market during the forecast period
The rising incidences of sports-related injuries and lower back pain are supporting the growth of surgical sealants across the globe. The increasing number of surgical procedures globally along with the high prevalence of lifestyle diseases is further fueling the segment growth.
By Source, Natural/Biologics Products holds the largest market share
Natural source products include sealants such as fibrin, collagen-based, gelatin-based, albumin-based and polysaccharide-based sealants among others. By origin, natural/biological sealants and adhesives include human blood-based and animal-based sealants. The availability of a wide range of natural/biologic sourced products is driving market growth.
By application, general surgery segment dominated the market in the year 2018
The technological advancements coupled with the increasing adoption of advanced surgical procedures in developing economies are favoring the growth of general procedures. Moreover, the general surgery segment is also expected to grow at the fastest rate over the forecast period owing to increasing surgical procedures for the treatment of diseases involving the skin, soft tissues, and hernias. Furthermore, surgeries of the abdomen, stomach, oesophagus, bowel, colon, liver, pancreas, gallbladder and bile ducts, and reconstructive, urological, and hernia-repair surgeries are involved in general surgery segment.
North America accounted for the largest market share in the year 2018
In 2018, North America dominated the biosurgery market with the maximum number of shares and the region is also expected to maintain its dominance over the forecast period owing to the presence of well-established healthcare infrastructure. The region is gaining notable growth owing to the easy accessibility to advance technology in the healthcare industry. The growing geriatric population along with the increasing number of surgical procedures is further contributing to the regional market growth. The rising prevalence of chronic diseases particularly cardiovascular diseases and cancer are supporting the demand for biosurgery in the regional market. In addition, the US witnessed the highest growth in the regional market. The increasing government funding and investment in the region are fuelling market growth. Apart from these, Asia Pacific is expected to be the fastest-growing region over the forecast period owing to increasing disposable income and ongoing development of healthcare infrastructure. Additionally, favorable government support and rising investment by global players in the region are also expected to contribute to the regional market growth.
The players profiled in the report include Ethicon, Sanofi, Baxter, Integra LifeSciences Corporation, Medtronic Plc, B. Braun Melsungen AG, Pfizer Inc, Stryker, and CSL. The major players are involved in mergers and acquisition, partnerships and new product developments for expanding the market share and also for gaining the competitive advantage.
The market research study on “Biosurgery Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”, offers detailed insights on the global biosurgery market entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global biosurgery market, its product, sources, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global biosurgery market size and volume, and segment markets by product, sources, application, and geography along with the information on companies operating in the market. The biosurgery market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
Market By Product
Market By Source
Market By Application
Market By Geography
Middle East & Africa
Biosurgery is a term used for surgical techniques that uses a wide range of natural and manmade materials, where biomaterials are biologically compatible glues and lubricants and the term also covers the biocompatible materials.
Some of the common biosurgery products are surgical sealants and adhesives, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple line reinforcement agents.
According to the research done by Acumen Research and Consulting, the global biosurgery market is expected to reach the market value of around 19,940Mn by 2026.
The global biosurgery market is expected to grow at a CAGR of around 7.9% from 2019 to 2026.
The general surgery segment dominated the biosurgery market in the year 2018 and the segment is also expected to lead the market through the forecast timeframe.
The growing aging population, high prevalence of chronic diseases, increasing number of surgical procedures, technological advancements and favorable government initiatives are expected to be the major drivers for the biosurgery market.
The major players include Ethicon Inc., Sanofi, Baxter, Integra LifeSciences Corporation, Medtronic Plc, B. Braun Melsungen AG, Pfizer Inc, Stryker, and CSL Behring.